Pricing Log in Create free account

DBV Technologies S.A. (DBVT) vs Sagimet Biosciences Inc. (SGMT)

DBV Technologies S.A. and Sagimet Biosciences Inc. are both Biotechnology companies. DBV Technologies S.A. and Sagimet Biosciences Inc. are of similar size ($641.5M and $615.8M). Sagimet Biosciences Inc. has the higher net margin (0.00% vs −5,547.3%) and the lower return on invested capital (−205.2% vs 0.00%). Across the 14 metrics below, Sagimet Biosciences Inc. leads on 10 and DBV Technologies S.A. on 4.

Valuation

Metric DBVT SGMT Biotechnology median
P/E n/m n/m 10.60
P/S 255.21 n/m 9.40
P/B 6.42 2.04 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 210.91 n/m 9.02
Earnings yield (29.23%) (13.03%) (32.88%)
Free cash flow yield (20.11%) (8.00%) (23.13%)

Profitability

Metric DBVT SGMT Biotechnology median
Gross margin 100.00% 0.00% 68.51%
Operating margin (5,571.63%) 0.00% 0.00%
Net margin (5,547.30%) 0.00% 0.00%
Free cash flow margin (5,131.50%) 0.00% 0.00%
Return on equity (205.75%) (24.37%) (51.96%)
Return on assets (127.19%) (23.49%) (46.06%)
Return on invested capital 0.00% (205.24%) 0.00%

Growth

Metric DBVT SGMT Biotechnology median
Revenue growth (TTM) (33.42%) — 6.76%
EPS growth (last fiscal year) 10.26% (8.97%) 29.88%
Revenue growth, 5-year CAGR (12.95%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DBVT SGMT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.24 45.02 4.97
Net debt to EBITDA 1.35 1.98 1.01

Dividend

Metric DBVT SGMT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DBVT SGMT Biotechnology median
Market cap 615.83m 641.51m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack